BioMosae

Geleen, Netherlands · Founded 2018 · Privately Held (backing)

Developer of metabolite-based biofungicides designed to control plant diseases through non-living microbial compounds. BioMosae is based in Geleen, Netherlands and was founded in 2018. Its last reported valuation was $2.5 million in Sep 2022. It has raised $3.7 million.

Last reported valuation

$2.5M

Oct 2026

Priced at

—

Total raised

$3.7M

Last round

—

How much has BioMosae raised?

$3.7Macross 0 recorded rounds

Free account

More of BioMosae with a free account

·Watch BioMosae: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

BioMosae investors

2 investors are on record for BioMosae, including StartLife and Limburg Development and Investment Company.

For fundraisers

Raising for a company like BioMosae?

2 investors have backed BioMosae.

See all 2 investors →

Frequently asked about BioMosae

How much has BioMosae raised?: BioMosae has raised $3.7M in total across 0 recorded funding rounds.